Status:
ACTIVE_NOT_RECRUITING
Impact of COVID-19 on GU Disease
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
COVID-19 Infection
Genitourinary Cancer
Eligibility:
All Genders
40+ years
Brief Summary
The purpose of this research study is to identify patients with GU disease with active or past COVID-19 infection. Participants will be asked to: * Complete an Online COVID-19 Questionnaire. * Discl...
Detailed Description
COVID-19 has a higher incidence in males compared to females and cancer patients have a higher risk of contracting COVID-19, and developing complications, and deteriorate more rapidly. COVID19 pandemi...
Eligibility Criteria
Inclusion
- Subjects must be men and women 40 years of age or older
- Subjects at risk or with GU cancer (Prostate, Bladder, Kidney)
- Subjects with benign GU disorders ( BPH, UTI, Bladder infection and kidney stone)
- Subjects must have a GU disease that requires clinic visit as determined by physician or healthcare provider following a telehealth appointment
- Willing and able to provide blood and urine samples
- Willing and able to complete a questionnaire to determine the COVID-19 symptoms.
- Willing and able to sign informed consent form
Exclusion
- Men and women below 40 years of age
- Subjects do not have a GU disease
Key Trial Info
Start Date :
February 18 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2026
Estimated Enrollment :
15240 Patients enrolled
Trial Details
Trial ID
NCT04761107
Start Date
February 18 2021
End Date
February 1 2026
Last Update
January 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029